Patient Derived Tumor Organoid Lines
Explore our expanding portfolio of patient-derived tumor organoid lines, including models derived from circulating tumor cells and primary tumor tissue, developed to support translational research and drug discovery. Our lines are available for purchase and can be paired with custom culture, expansion, and assay development services to meet the specific needs of your research program.
For any additional information, please reach out to us at: purchase@cellentiabio.com
CTC-Colon
Species: Human
Cancer: Colorectal Cancer
Subtype: N/A
Type: Circulating Tumor Cell
Age: 80
Race: Caucasian
Gender: Female
CTC-Renal
Species: Human
Cancer: Renal Carcinoma
Subtype: N/A
Type: Circulating Tumor Cell
Age: 61
Race: Caucasian
Gender: Male
DTC-PDAC
Species: Human
Cancer: Pancreatic Ductal Adenocarcinoma
Subtype: N/A
Type: Dissociated Tumor Cell
Age: 65
Race: Caucasian
Gender: Female
BRCA-003
Species: Human
Cancer: Breast
Subtype: N/A
Type: Dissociated Tumor Cell
Age: 57
Race: Caucasian
Gender: Female
CB-18
Species: Human
Cancer: Breast
Subtype: Triple Negative
Type: Circulating Tumor Cell
Age: 65
Race: Hispanic
Gender: Female
CB-22
Species: Human
Cancer: Glioblastoma
Subtype: N/A
Type: Circulating Tumor Cell
Age: 66
Race: Caucasian
Gender: Female